Management Team

Aino Kalervo

MSc, MS, Chief Business Officer

Chief Business Officer, Aino Kalervo, is trained in both molecular biology and business and has over a decade’s experience in the business development of early stage biologics and therapeutic vaccines. Prior to joining TILT, Aino worked at Sanofi’s Paris office and Theravectys, a French therapeutic vaccine company. Aino is responsible for all aspects of business, including fund raising, business development, and bridging the gap from breakthrough science to product success.

Akseli Hemminki

MD, PhD, eMBA, Founder & CEO and Chairman of the Board

Kari Varkila

MD, PhD, MBA, Chief Medical Officer

Tuija Keinonen

PhD, Chief Regulatory Officer

Elina Haavisto

MSc, Head of CMC Regulatory Affairs

Claudia Kistler

PhD, Head of Clinical Operations

Víctor Cervera-Carrascón

M.Pharm, Head of Immunology

Riikka Havunen

PhD, Head of R&D

Riikka Kalliokoski

Bachelor of Social and Health Care, Lab manager

João Manuel Santos

MSc, Head of Cell Therapy

no image

Suvi Sorsa

PhD, Head of Clinical Research

Remi Gloeckler

PhD, CMC Advisor